S.Korea's Hanmi Pharm soars, diabetes drug enters phase 2 clinical trial

Hanmi Science

10/04/2018 04:00

** Shares of Hanmi Pharm Co Ltd  128940.KS  jump nearly 9
pct to a two-month high
    ** Hanmi Pharm's drug for diabetes entered into phase 2
clinical trial with two more trials scheduled for H1 of this
year, an analyst with SK Securities said in a note
    ** Hanmi Science  008930.KS , Hanmi Pharm's holding company,
also up 5.4 pct
    ** Broader market  .KS11  up 0.3 pct as of 0248 GMT

 ((Reuters Messaging: dahee.kim@thomsonreuters.com))